UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

PloS one, 2021-06, Vol.16 (6), p.e0253081-e0253081

2021

Link zum Volltext

Verfügbarkeit prüfen

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

BMJ Oncology, 2023-12, Vol.2 (1), p.e000039

2023

Link zum Volltext

Verfügbarkeit prüfen

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (5), p.2136-2140

2010

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.235-239

2006

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

European urology, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

European urology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study

PloS one, 2021-06, Vol.16 (6 June 2021)

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024

European urology, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11

European urology, 2013-11, Vol.64 (5), p.711-712

2013

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11: Should Men Older Than Age 70 Be Recommended Against Screening?

European urology, 2013-11, Vol.64 (5), p.711-712

2013

Link zum Volltext

Verfügbarkeit prüfen

The quality of radical prostatectomies must be ensured

Läkartidningen, 2017-07, Vol.114

2017

Link zum Volltext

Verfügbarkeit prüfen

The impact of design and performance in PSA screening: differences between ERSPC centers

European urology, 2019-04, Vol.76 (3), p.276-279

2019

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer - diagnostics and screening: Prostatacancer – utredning, klinisk diagnostik och screening

Läkartidningen, 2024, Vol.121

2024

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.87-87

2019

Link zum Volltext

Verfügbarkeit prüfen

Kvaliteten på radikal prostatektomi måste säkerställas: fortlöpande förbättringsarbete behövs på varje klinik - med patientenkäter kan enskilda kirurgers resultat följas upp

Läkartidningen, 2017, Vol.114 (27-29)

2017

Link zum Volltext

Verfügbarkeit prüfen

Correction: Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

Hernia : the journal of hernias and abdominal wall surgery, 2022-04, Vol.26 (2), p.683-683

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.110-110

2018

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: Urs E. Studer, Peter C. Albertsen. It's Time to Change the Treatment Paradigm for Prostate Cancer! Eur Urol 2013;63:97–9

European urology, 2013-01, Vol.63 (1), p.99-100

2013

Link zum Volltext

Verfügbarkeit prüfen

Four‐hundredfold overestimation of biopsy mortality

BJU international, 2013-03, Vol.111 (3), p.E16-E17

2013

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer screening in Europe – Authors' reply

The Lancet (British edition), 2015-04, Vol.385 (9977), p.1507-1508

2015

Link zum Volltext

Verfügbarkeit prüfen

Screening for Prostate Cancer Starting at Age 50-54. A Population-based Cohort Study

European urology, 2016-04, Vol.71 (1), p.46-52

2016

Link zum Volltext

Verfügbarkeit prüfen

Oncologic and functional outcomes between open and robotic radical prostatectomy at 24-months follow-up in the Swedish LAPPRO trial

European urology, 2018, Vol.1 (5), p.353

2018

Link zum Volltext

Verfügbarkeit prüfen

90-Day readmission after radical prostatectomy-a prospective comparison between robot-assisted and open surgery

Scandinavian journal of urology, 2019, Vol.53 (1), p.26-33

2019

Link zum Volltext

Verfügbarkeit prüfen

Social constraints and psychological well‐being after prostate cancer: A follow‐up at 12 and 24 months after surgery

Psycho-oncology (Chichester, England), 2018-02, Vol.27 (2), p.668-675

2018

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial” [Eur Urol 2013;64:703–9]

European urology, 2015-08, Vol.68 (2), p.e46-e46

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

ThemaProstate-Specific Antigen - Blood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11: Should Men Older Than Age 70 Be Recommended Against Screening?

The quality of radical prostatectomies must be ensured

The impact of design and performance in PSA screening: differences between ERSPC centers

Prostate cancer - diagnostics and screening: Prostatacancer – utredning, klinisk diagnostik och screening

Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making

Kvaliteten på radikal prostatektomi måste säkerställas: fortlöpande förbättringsarbete behövs på varje klinik - med patientenkäter kan enskilda kirurgers resultat följas upp

Correction: Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM)

Reply from Authors re: Urs E. Studer, Peter C. Albertsen. It's Time to Change the Treatment Paradigm for Prostate Cancer! Eur Urol 2013;63:97–9

Four‐hundredfold overestimation of biopsy mortality

Prostate cancer screening in Europe – Authors' reply

Screening for Prostate Cancer Starting at Age 50-54. A Population-based Cohort Study

Oncologic and functional outcomes between open and robotic radical prostatectomy at 24-months follow-up in the Swedish LAPPRO trial

90-Day readmission after radical prostatectomy-a prospective comparison between robot-assisted and open surgery

Social constraints and psychological well‐being after prostate cancer: A follow‐up at 12 and 24 months after surgery

Corrigendum to “Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial” [Eur Urol 2013;64:703–9]

Aktive Filter

Suchergebnisse filtern